PMPRB communiqué (June 28, 2007) regarding ATP calculation for January – June 2007 data filing

The PMPRB has posted another communiqué dated June 28, 2007 regarding compassionate programs and the ATP calculation for the January –July 2007 filing:

1. Give the timing of the LEO Pharma FCC decision, the “Board will not require any change in the manner in which average transaction prices for [the January –July] period are calculated relative to prior reporting periods.”

2. “Patentees may elect to include or exclude all benefits and reductions in the calculations of average transaction prices for January – June 2007 provided that this is consistent with their calculations in prior periods.”

3. Board will “advise patentees shortly of the requirements for subsequent periods.”

4. Board is looking at operational options with respect to compassionate programs that will be consistent with the law.

Copaxone Hearing

Board Staff counsel presented closing arguments on June 27 in the Copaxone hearing. While Copaxone is the lowest priced comparable medicine, Board Staff claim that a 2004 price increase was in excess of the CPI methodology found in the Board’s Excessive Price Guidelines.

Board_Communiqué-June_28_0738IAD-6292007-7975.pdf